A significant portion of HCC initiation and recurrencies derived by tumor initiating stem cell-like cells (TICs), whose marker CD133 expression level is negatively correlated with the final outcome of HCC patients (Wu J. et al., 2024). The gene discussed is PROM1; the disease is hepatocellular carcinoma.